Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Aivita Biomedical, Altimmune, Ampio, Aslan, Biontech, Chimerix, Constant, Glaxosmithkline, Gtreebnt, I-Mab, Innovation, Innovent Biologics, LG Chem Life Sciences, Neurorx, Novavax, Opthea, Partner, Pfizer, Redhill, Regeneron, Regentree, Revive, Samsung Bioepis, Stero, Takeda, Takis, Theravance, Union.